Up-Titration Strategy After DPP-4 Inhibitor-Based Oral Therapy for Type 2 Diabetes: A Randomized Controlled Trial Shifting to a Single-Dose GLP-1 Enhancer Versus Adding a Variable Basal Insulin Algorithm

INTRODUCTION: It is unclear whether adding basal insulin or enhancing incretin signaling with a glucagon-like peptide-1 receptor agonist (GLP-1RA) is more effective as an up-titration strategy after dipeptidyl peptidase-4 inhibitor (DPP-4i)-based oral antidiabetic drug (OAD) therapy. GLP-1RAs can be...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyagi, Masahiko, Uchino, Hiroshi, Kumashiro, Naoki, Higa, Mariko, Shin, Koki, Sasamoto, Makiko, Kitazato, Hiroji, Tamaki, Motoyuki, Matsuhisa, Munehide, Hirose, Takahisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167274/
https://www.ncbi.nlm.nih.gov/pubmed/30121725
http://dx.doi.org/10.1007/s13300-018-0486-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167274/
https://www.ncbi.nlm.nih.gov/pubmed/30121725
http://dx.doi.org/10.1007/s13300-018-0486-1

Ejemplares similares